Medicare coverage for the FreeStyle Libre systems (CGM)

Due to the COVID-19 pandemic, more Medicare patients with diabetes are currently eligible* for coverage of the FreeStyle Libre 2 system or the FreeStyle Libre 14 day system.

NOW YOU KNOW

CGM = continuous glucose monitoring 

Start by filling your prescription

Ask your healthcare professional for a prescription. It must include both the reader and sensors to be eligible†‡§‖ for Medicare coverage. Our Medicare Guide includes a list of suppliers who can help you understand your coverage and fill your prescription for the system you prefer.

Unsure how to ask your doctor about continuous glucose monitoring? We can help! 

Use our Discussion Guide to help navigate the conversation with your doctor. The guide will help you understand personal diabetes management challenges and give you a list of questions to ask at your next visit.

 

The FreeStyle Libre systems (CGM) could be right for you! You can monitor your glucose and receive alarms on your smartphone# or FreeStyle Libre 2 reader without fingersticks.†**††
 
 

Already have one of the FreeStyle Libre systems (CGM)?

Learn how to set up your system today.
Get started

Woman with CGM sensor

Have more questions?

We'll help you find the answers.
Explore FAQs

Man wearing a FreeStyle Libre sensor

As a courtesy, Abbott provides the most up-to-date information available, but it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors.

* On May 8, 2020, CMS published a second interim final rule with comment, CMS-5531-IFC, that expanded the non-enforcement of clinical indications of coverage to therapeutic continuous glucose monitors (CGMs). (www.govinfo.gov/content/pkg/FR-2020-05-08/pdf/2020-09608.pdf) The Durable Medical Equipment Medicare Administrative Contractors (DME MAC) subsequently issued guidance on the IFC policies, including discussing that clinical indications for coverage in the therapeutic CGM LCD (Glucose Monitors, L33822) will not be enforced. See “CMS Issues Interim Final Rules with Comment (CMS-1744-IFC & CMS-5531-IFC) – COVID-19 Public Health Emergency – Revised May 21, 2020.” (www.cgsmedicare.com/jc/pubs/news/2020/05/cope1733) As a courtesy to its customers, Abbott provides the most up-to-date information available, but it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third-party coverage of payment for our products or reimburse customers for claims that are denied by third-party payors.

† Medicare coverage is available for the FreeStyle Libre 2 system if a compatible smartphone is used in conjunction with the FreeStyle Libre 2 reader to review glucose data. Medicare and other third party payor criteria apply.

‡ FreeStyle Libre 14 day sensors communicate with the FreeStyle Libre 14 day readers that started them or the FreeStyle LibreLink app that started it. A sensor started by the FreeStyle Libre 14 day reader will also communicate with the FreeStyle LibreLink app once the FreeStyle LibreLink app is used to scan the sensor.

§ You cannot use both the FreeStyle Libre 2 reader and the FreeStyle Libre 2 app to scan the same FreeStyle Libre 2 sensor for glucose readings. If you start the Sensor with the App, then you cannot use the Reader to scan for glucose readings and if you start the Sensor with the Reader, then you cannot use the App to scan for glucose readings. Whichever device you start the Sensor with will receive alarms.

‖ Medicare coverage is available for FreeStyle Libre 14 day systems for cell phone use if FreeStyle LibreLink is used in conjunction with the FreeStyle Libre 14 day readers. Patients must meet Medicare eligibility coverage criteria LCD L33822 (July 2021). Local Coverage Article: Glucose Monitor Policy Article (A52464), July 2021.

¶ Notifications will only be received when alarms are turned on and the sensor is within 20 feet unobstructed of the reading device. You must enable the appropriate settings on your smartphone to receive alarms and alerts, see the FreeStyle Libre 2 User’s Manual for more information.

# The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. Please check our compatibility guide for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app requires registration with LibreView.

** The FreeStyle Libre 2 app and the FreeStyle Libre 2 reader have similar but not identical features. Fingersticks are required for treatment decisions when you see the Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations. 

†† To get the Urgent Low Glucose Alarm on your phone with the FreeStyle Libre 2 app, you will first need to start your FreeStyle Libre 2 sensor with your phone. If you do not start your FreeStyle Libre 2 sensor with your phone, you will not get the Urgent Low Glucose Alarm on your phone.

ADC-37051 Ver 3.0 01/22

Important Safety Information

FreeStyle Libre 14 day system: Failure to use FreeStyle Libre 14 day system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.

FreeStyle Libre 2: Failure to use FreeStyle Libre 2 system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose alarms and readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.

The product images are for illustrative purposes only.

The circular shape of the sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.

No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.

This website and the information contained herein is intended for use by residents of the United States.

ADC-29111 Ver 9.0 01/22

Cookie Policy.

FreeStyle Libre uses cookies to give you the best possible service. By using our website, you consent to the use of cookies. More on this